A cloud-based solution that enhances the efficiency of multidisciplinary tumor board meetings, supporting the essential functions of coordination, presentation and documentation—including automatically capturing, customizing and reporting key metrics essential for accreditation and quality measures.
A cloud-based solution that enhances the efficiency of multidisciplinary tumor board meetings, supporting the essential functions of coordination, presentation and documentation—including automatically capturing, customizing and reporting key metrics essential for accreditation and quality measures.
Without the support of a digital platform, tumor boards can be labor intensive and add additional administrative burden. Navigating among multiple systems, meeting participants can lose time and focus from achieving consensus on patient treatments.
aggregates and displays pertinent patient data all in one place to support multidisciplinary team decisions.
enables multidisciplinary oncology care teams to work together more effectively. Schedule meetings more easily. Conveniently and securely access, review, and share pertinent tumor board patient data across the network. Track and report accreditation analytics. Have clear sight into guidelines and available clinical trials. And—most importantly—quickly arrive at the best care plan for tumor board cases.
Enable quicker tumor board treatment decisions through integrated and standardized data.1
Streamline and reduce burden for multidisciplinary team meeting preparation across the healthcare network.2
Easy access to secured patient data and virtual meetings can increase tumor board participation and quality.
Capture accreditation and quality metrics as part of the tumor board process to support quality programs.
For cancer centers, accreditation is a declaration of quality in patient care, operations and business practice. eliminates the challenges and risks associated with manual data entry by aggregating, measuring and providing accurate, timely reporting on the key metrics required for accreditation and quality improvement initiatives.
helps physicians collect all of the data in one place so that we can make an informed decision.
Richard Hammer, MD
Vice-Chair of Pathology, University of Missouri
University of Missouri (MU) Ellis Fischel Cancer Center is recognized as a leader in cancer care, with state-of-the-art facilities and technologies. MU’s multidisciplinary, highly collaborative approach ensures a personalized treatment plan for each patient. Implementing across four tumor boards achieved a reduction in per-case discussion costs of 40-52%.*3
* The results are specific to MU. This is not a guarantee of results.
Study method:
In this large prospective study across multiple tumor board specialties, demonstrated improved workflow efficiency, resulting in a significant and consistent reduction in overall preparation time.
average reduction in overall preparation time across three different tumor boards
A 76% variance (standard deviation) reduction in preparation time (p=0.036) was observed in the breast tumor board across 59 meetings.
variance reduction
Two prospective multi-year studies reveal how impacts multidisciplinary team meetings, specifically case preparation, case discussion time and postponement of cases in tumor boards.
Watch authors Dr. Richard D. Hammer and Dr. Matthew Prime discuss sustained benefits at the University of Missouri (MU) Ellis Fischel Cancer Center.
Virtual options support optimization of clinicians’ time from preparation to meeting conduction.
Explore
more
References & notes
* The results are specific to Ellis Fischel based on multiple Ellis Fischel tumor board sites. The data is available upon request. This is not a guarantee of results.
Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050
